Search Within

Leslie Ann Perez

Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
Groups
  1. Department of Medicine (14)
  2. Advanced Practice Providers (11)
  3. Center for Hematologic Malignancies (11)
  4. GSK Faculty (11)
  5. Hematologic Malignancies, Division of (11)
  6. Lymphoma (11)

More Groups

People
  1. Alison Moskowitz (11)
  2. Helen Hancock (11)
  3. Nivetha Ganesan (11)
  4. Steven Horwitz (11)
  5. Theresa Davey (11)
  6. Natasha Galasso (10)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (4)
  4. 2022 (1)
  5. 2021 (4)
  6. 2020 (1)

More Years

Publications
  1. Blood (4)
  2. Hematological Oncology (4)
  3. Journal of Clinical Oncology (3)
  4. Journal of Thoracic Oncology (2)
  5. Nature Medicine (1)
  6. Oncology Nursing Forum (1)
Publishers
  1. American Society of Hematology (4)
  2. Wiley Blackwell (4)
  3. American Society of Clinical Oncology (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (1)
  6. Oncology Nursing Society (ONS) (1)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • External versus internal urinary drainage catheters and catheter acquired urinary tract infections in inpatient oncology
    Meeting Abstract

    Holbrook, H.; Perez, L.; Gill, B.
    Oncology Nursing Forum (2020)

    Fulltext@MSK | Save
  • A Phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib
    Journal Article

    Yu, H. A.; Perez, L.; Chang, Q.; Gao, S. P.; Kris, M. G.; Riely, G. J.; Bromberg, J.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase I trial of certolizumab plus chemotherapy in patients with stage IV lung adenocarcinomas
    Meeting Abstract

    Paik, P. K.; Eng, J.; Perez, L.; Ritter, E.; Ni, A.; Ng, K. K.; Fiore, J. J.; Wong, P.; Rudin, C. M.; Massague, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy
    Meeting Abstract

    Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save